The Gabelli Healthcare & Wellness Trust (GRX) AI Stock Analysis

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund managed by Gabelli Funds, LLC under GAMCO Investors, Inc. Established on February 20, 2007, the fund invests primarily in global public equity markets, targeting companies across all market capitalizations within the healthcare and wellness sectors. It aims to capture opportunities generated by advancements and innovations in these industries. The fund benchmarks its performance against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index, while monitoring financial developments like cryptocurrency.

The fund experienced wide fluctuations in financial results across recent fiscal years. Revenue climbed 73.9% to $43.5M in FY2021 before falling 207.4% to -$46.7M in FY2022, resulting in a net loss of -$47.4M. In FY2023, revenue recovered to $4.0M with net income of $422,802. Revenue fell 18.8% in FY2024 to $3.3M with net income of -$285,000. In FY2025, revenue rebounded 368.7% to $15.3M, supported by an operating margin of 31.0% and net income of $2.3M. Over the five years from FY2020 to FY2025, revenue generated a compound annual growth rate of -9.4%. For the trailing twelve months ending June 30, 2026, revenue was $0, with diluted EPS of $0.57.

As of June 30, 2026, the fund held cash and short-term investments of $2,121 alongside total debt of $69.8M, yielding net debt of $69.8M and a current ratio of 0.06. Total assets stood at $229.0M against shareholders' equity of $153.1M, reflecting a debt-to-equity ratio of 0.46. In FY2025, operating cash flow reached $9.4M and free cash flow was $9.4M after capital expenditures of $3. Cash deployment in FY2025 included $4.4M in share buybacks and $10.1M in dividends paid.

At a market cap of $146.8M and a last close of $10.09, GRX trades at a trailing price-to-earnings multiple of 17.7x and a price-to-sales ratio of 17.1x, above the median of its US-listed Financial Services peers of 12.1x and 3.2x, respectively. Its price-to-book ratio is 0.9x, and enterprise value is $0. Over the past year, GRX generated an 18.5% return, outpacing the S&P 500 return of 16.8%. However, over five years, GRX returned 6.9%, trailing the S&P 500 return of 83.0%.

GRX pays a quarterly dividend with an annualized forward payout of $0.68, representing a dividend yield of 6.74%. The fund has paid dividends for 15 consecutive years, delivering a 5-year annualized dividend growth rate of 2.6%. Its payout ratio stands at 119.3%, and the most recent ex-dividend date was September 16, 2026.

Analyst rating counts and forward consensus price targets are not available for GRX. Across recent quarterly reports, the fund recorded 2 EPS beats over the last 4 quarters. Institutional ownership stands at 40.9%, while insiders control 1.8% of outstanding equity. Short interest as a percentage of float is 0.1%, with shares closing at $10.09 on October 16, 2026, which is 9.5% above its 200-day average.

This page is an AI-written research summary of The Gabelli Healthcare & Wellness Trust (GRX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: GRX income statement, GRX balance sheet, GRX key metrics, GRX chart. See the GRX stock overview for the latest quote and news.